Boston Trust Walden’s CyrusOne Inc Common Stock CONE Stock Holding History

Boston Trust Walden’s Portfolio CONE Stock Details CONE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-199,965	Closed	-$15.5M	–	401
2021 Q3	$15.5M	Buy	199,965 +2,118	+1%	+$159K	0.14%	186
2021 Q2	$14.2M	Buy	197,847 +13,317	+7%	+$970K	0.13%	198
2021 Q1	$12.5M	Buy	184,530 +21,180	+13%	+$1.47M	0.12%	200
2020 Q4	$11.9M	Buy	163,350 +61,904	+61%	+$4.49M	0.13%	196
2020 Q3	$7.11M	Buy	101,446 +1,674	+2%	+$131K	0.09%	213
2020 Q2	$7.26M	Buy	+99,772	New	+$7.1M	0.1%	208

Other funds holding CONE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Trust Walden's CONE Position: Q4 2021 in Review

Boston Trust Walden sold out of CyrusOne Inc Common Stock (CONE) in Q4 2021, closing a stake of 199,965 shares — an estimated $15.5M sold.

Boston Trust Walden first reported a position in CONE in Q2 2020 and held it in 6 quarters. The position peaked at $15.5M in Q3 2021. 469 funds tracked by Wall St. Rank hold CONE as of Q4 2021.

Boston Trust Walden reported no remaining CyrusOne Inc Common Stock position as of Q4 2021 after selling out during the quarter.
Boston Trust Walden sold 199,965 CyrusOne Inc Common Stock shares in Q4 2021, an estimated $15.5M.
Boston Trust Walden first reported a position in CyrusOne Inc Common Stock in Q2 2020 and held it in 6 quarters.
Boston Trust Walden's CyrusOne Inc Common Stock position peaked at $15.5M in Q3 2021.
469 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q4 2021.

Based on Boston Trust Walden's 13F filing for Q4 2021, filed 21 Jan 2022.